Is Nexalin Technology, Inc. (NXL) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.0% / 30% | 42.3% / 30% | 0.2% / 30% | 82.63% / 5% | ✗ NOT HALAL |
| DJIM | 0.0% / 33% | 42.3% / 33% | 0.2% / 33% | 82.63% / 5% | ✗ NOT HALAL |
| MSCI | 0.0% / 33% | 82.4% / 33% | 0.3% / 33% | 82.63% / 5% | ✗ NOT HALAL |
| S&P | 0.0% / 33% | 42.3% / 33% | 0.2% / 33% | 82.63% / 5% | ✗ NOT HALAL |
| FTSE | 0.0% / 33% | 82.4% / 33% | 0.3% / 50% | 82.63% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 79.7% | |
| Operating Margin | -1403.9% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -221.5% | |
| Return on Assets (ROA) | -118.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$4M |
| Free Cash Flow | -$4M |
| Total Debt | $0 |
| Current Ratio | 4.8 |
| Total Assets | $4M |
Price & Trading
| Last Close | $0.38 |
| 50-Day MA | $0.50 |
| 200-Day MA | $0.89 |
| Avg Volume | 335K |
| Beta | 4.1 |
|
52-Week Range
$0.36
| |
About Nexalin Technology, Inc. (NXL)
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Nexalin Technology, Inc. (NXL) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Nexalin Technology, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Nexalin Technology, Inc.'s debt ratio?
Nexalin Technology, Inc.'s debt ratio is 0.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.0%.
What are Nexalin Technology, Inc.'s key financial metrics?
Nexalin Technology, Inc. has a market capitalization of $7M, and revenue of $168,721. Return on equity stands at -221.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.